<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-CPW1HEZ9</identifier><date>2014</date><creator>Čerček, Miha</creator><relation>documents/doc/C/URN_NBN_SI_doc-CPW1HEZ9_001.pdf</relation><relation>documents/doc/C/URN_NBN_SI_doc-CPW1HEZ9_001.txt</relation><format format_type="issue">2</format><format format_type="volume">65</format><format format_type="type">article</format><format format_type="extent">str. 137-140</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">28105255</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-CPW1HEZ9</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">akutni koronarni sindrom</subject><subject language_type_id="slv">antiagregacijsko zdravljenje</subject><subject language_type_id="slv">ateroskleroza</subject><subject language_type_id="slv">krvavitev</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>Antiagregacijska zdravila</title><title>Antiplatelet therapy</title><title>indications, guidelines and clinical practice</title><title>indikacije, smernice in klinična praksa</title></Record>